NLRP3 and Alzheimer disease: According to Zhang et al., abnormal glutamine metabolism in microglia under AD pathology suppresses mitophagy through the AMPK/mTORC1 signaling pathway, resulting in reactive oxygen species (ROS) accumulation and selective activation of the NLRP3 inflammasome.